Design Therapeutics Stock (NASDAQ: DSGN) stock price, news, charts, stock research, profile.
You can purchase shares of Design Therapeutics (NASDAQ:DSGN) through any online brokerage.
Other companies in Design Therapeutics’s space includes: Larimar Therapeutics (NASDAQ:LRMR), Tevogen Bio Holdings (NASDAQ:TVGN), Sangamo Therapeutics (NASDAQ:SGMO), Anika Therapeutics (NASDAQ:ANIK) and Silence Therapeutics (NASDAQ:SLN).
Design Therapeutics has a consensus price target of $6.75.
The stock price for Design Therapeutics (NASDAQ: DSGN) is $4.29 last updated February 7, 2025 at 4:00 PM EST.
There are no upcoming dividends for Design Therapeutics.
Design Therapeutics’s Q1 earnings are confirmed for Wednesday, May 7, 2025.
There is no upcoming split for Design Therapeutics.
Design Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.